The most frequent genetic alterations in patients with Ph‐like ALL are rearrangements of cytokine receptor like factor 2 (CRLF2),9 which are strongly associated with adverse clinical and treatment response factors and a higher risk of relapse with conventional therapy. Here, CRLF2 is linked to acute lymphoblastic leukemia.